Abstract The Cagritirz 70mg peptide pen is the highest concentration research variant currently available in this class, representing the apex of combinatorial metabolic engineering. This ultra-potency formulation contains a dense molar ratio of Cagrilintide and Tirzepatide, specifically developed for research protocols involving severe metabolic rigidity and recalcitrant obesity models. By delivering a massive pharmacological load in a standard 3ml volume, this pen allows researchers to investigate physiological responses at the absolute limits of receptor saturation. It is primarily utilised in “rescue” studies where subjects have ceased responding to lower-dose interventions, or in deep-phenotyping trials aiming to overcome profound insulin resistance through aggressive, multi-pathway agonism.

Mechanism and Research Interest

Primary Biological Pathway: Overcoming Metabolic Resistance The 70mg formulation is designed to address the phenomenon of “tachyphylaxis” or receptor downregulation often seen in chronic metabolic studies. In models of super-obesity or advanced Type 2 Diabetes, cellular receptors may become desensitised to standard incretin signals. The Cagritirz 70mg variant provides the necessary ligand density to re-engage these dormant pathways. By flooding the synaptic clefts and receptor sites of the GLP-1, GIP, and Amylin systems, this compound forces a signal transduction event, allowing researchers to observe if metabolic “breakpoints” can be reversed pharmacologically.

Secondary Research Finding: Deep Tissue Penetration and Retention Higher concentration gradients can influence the pharmacokinetics of tissue distribution. Research utilizing the 70mg variant often focuses on the retention of the peptide in deep visceral adipose tissue. The hypothesis is that the higher molar concentration facilitates a more profound permeation of the lipid bilayer in adipocytes, leading to more sustained downregulation of lipogenic genes (SREBP-1c) compared to lower-concentration controls. This is critical for studies aiming to reduce visceral adiposity index (VAI) in rapid timeframes.

Tertiary Research Finding: Supraphysiological Satiety Signalling In the central nervous system, the 70mg concentration allows for the investigation of the upper limits of the “gut-brain axis.” Researchers are documenting the effects of maximal amylin and GLP-1 stimulation on the nucleus of the solitary tract. Specifically, studies are looking for “ceiling effects”—points at which increased dosage no longer yields increased satiety—to map the absolute total capacity of the neuroendocrine system to regulate intake. This data is vital for defining the toxicological and efficacy boundaries of multi-agonist therapies.

Long-term Genomic and Safety Observations With such high potency, the focus of genomic safety shifts to cellular stress markers. Researchers are rigorously monitoring for signs of endoplasmic reticulum (ER) stress in pancreatic beta-cells. While GIP is protective, the massive secretory demand placed on the pancreas by such a potent secretagogue requires careful observation. Current studies are sequencing RNA to ensure that the 70mg dose stimulates insulin secretion without inducing beta-cell exhaustion or apoptosis over long-term administration.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). Achieving this concentration requires advanced solubility techniques to ensure the peptide remains in solution without precipitating.

• Appearance: The 3ml pen contains a clear, highly viscous, sterile liquid. Due to the saturation level of the solution, it is noticeably thicker than the 15mg or 40mg variants.

• Precision: The pen is calibrated to handle the increased viscosity, ensuring accurate volumetric displacement for consistent dosing.

• Storage: Strict adherence to 2∘C to 8∘C is mandatory.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The Cagritirz 70mg Pen is an ultra-saturated solution. It must be stored at 2∘C to 8∘C at all times. The shelf life is 12 months sealed. Once opened, the high concentration makes the solution thermodynamically unstable if exposed to heat; precipitation is a risk. Researchers are advised to utilise the pen rapidly, ideally within 21-28 days, and to minimise the time the pen spends outside the refrigerator during experimental procedures.

Shipping Stability

The molecular stability of Cagritirz allows it to withstand ambient temperatures for up to 28 days.

This resilience is due to the specific pH buffering of the solution, ensuring the product arrives at your laboratory with its bioactivity fully intact.

Freezing Warning CRITICAL: DO NOT FREEZE. At 70mg concentration, the peptide is near its solubility limit. Freezing will almost certainly cause immediate and irreversible precipitation (crashing out) of the peptide from the solution. The result will be a solid white mass that will not re-dissolve upon thawing, rendering the costly sample totally unusable.

Why Choose the Peptide Pro 3ml Pen Format?

The Cagritirz 70mg Pen solves a critical logistical problem in high-dose research: Volume Intolerance. To administer a 70mg equivalent dose using standard 5mg or 10mg vials would require injecting fluid volumes that are ethically and experimentally unacceptable for small rodent models (causing hydrostatic shock or tissue necrosis).

This pen concentrates that massive dosage into a micro-litre friendly format. It allows for the delivery of “rescue-level” therapy without the confounding variable of volume overload. It is the only viable tool for high-resistance, high-dose protocols.

For researchers establishing a dose-response curve, we recommend the following titration path:

• Step 1 (Baseline): Cagritirz 15mg

• Step 2 (Escalation): Cagritirz 40mg

• Step 3 (Maximal): Cagritirz 70mg (Current Page)

Disclaimer

This product is strictly for Research Use Only (RUO). It is essentially a high-potency chemical reagent and is not intended for human consumption, injection, therapeutic use, or diagnostic procedures. The extreme concentration presents elevated risks if mishandled. Purchase is restricted to verified research institutions and principal investigators. Any evidence of intended misuse for human application will result in immediate legal reporting and permanent blacklisting, in accordance with UK regulations regarding research chemicals.